Valdemir Melechco Carvalho
Papers
3
Total Citations
155
H-Index
3
About
Valdemir Melechco Carvalho is a leading figure in clinical proteomics and infectious disease diagnostics, best known for pioneering mass spectrometry-based methods for rapid viral detection. His most impactful work, published in 2020, describes the development of a high-throughput targeted proteomics assay to detect SARS-CoV-2 nucleoprotein in large clinical cohorts, amassing 126 citations and demonstrating a scalable alternative to PCR-based testing during the pandemic. Carvalho’s major contributions lie in establishing fast, low-cost tandem mass spectrometry workflows for identifying viral peptides directly from patient samples—two complementary studies on this approach have garnered 18 and 11 citations respectively. By shifting the paradigm from nucleic acid amplification to protein-based detection, his research addresses critical bottlenecks in population screening, including reagent shortages and turnaround time. Carvalho’s work has been instrumental in advancing clinical proteomics as a frontline tool for pandemic response, showcasing how mass spectrometry can deliver both speed and accuracy in real-world diagnostics. His achievements highlight the power of interdisciplinary innovation at the intersection of analytical chemistry and virology, offering a blueprint for future outbreak preparedness.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3